The World Health Organization’s advisory vaccine safety panel said on Wednesday a causal link between the AstraZeneca COVID-19 vaccine and rare cases of blood clots with low platelets is “considered plausible but is not confirmed”.
The independent experts, in a statement issued after a review of the latest global data, said that specialized studies were needed to fully understand the potential relationship between vaccination and possible risk factors.
“It is important to note that whilst concerning, the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca COVID-19 vaccine around the world,” the panel said.
It added that it would meet against next week to review additional data.
Iraq reports 8,331 new COVID-19 cases in highest daily increaseIraq registered its biggest daily increase in coronavirus infections on Wednesday with 8,331 cases, taking its total so far to 859,622 including ... Coronavirus
No risks in COVID-19 vaccine switch after first AstraZeneca dose: German expertGermany’s vaccine advisory committee sees no disadvantages or risks from giving younger recipients of AstraZeneca’s COVID-19 vaccine a second dose of ... Coronavirus
Some Indian states warn of vaccine shortage as COVID-19 cases peakIndia reported a record 115,736 new COVID-19 cases on Wednesday, a 13-fold increase in just over two months, raising pressure on the government to ... Coronavirus